Apollo Hospitals Enterprise Ltd

Large Cap

Healthcare Sector

reflects a positive outlook for the share price

reflects a neutral outlook for the share price

reflects a negative outlook for the share price

The analysts information is for reference only and does not\n  represents an investment recommendation.

Analyst recommendation reflect the views of analysts who follow and write research reports.

Company Information is an introduction to the company’s business that details what it sell, how it was founded, what their mission is, how they manufacture or source their products, and why they serve customers.

Apollo Hospitals has completed its acquisition of Apollo Health and Lifestyle, increasing its stake to 100% by purchasing additional shares for Rs 18.69 crore.

Apollo Hospitals Completes Full Acquisition of AHLL - 10 Apr, 2026

Morgan Stanley maintains an Overweight rating on Apollo Hospitals Enterprise, adjusting the target price to ₹8,833 from ₹9,209 due to EBITDA cuts and higher operating costs, while the revenue outlook remains stable despite margin pressures.

Morgan Stanley Adjusts Target Price for Apollo Hospitals - 08 Apr, 2026

The National Company Law Tribunal (NCLT) has approved a deal plan for Apollo Hospitals involving Apollo HealthCo, Keimed, and Apollo HealthTech, with upcoming shareholder and creditor meetings.

NCLT Approves Apollo Hospitals Deal Plan - 04 Apr, 2026

Apollo Hospitals has enhanced its air ambulance services for better patient transfers and received a 'Buy' rating from Citi with a target price of Rs 9600, supporting a positive growth outlook.

Apollo Hospitals Expands Services and Maintains Growth Outlook - 30 Mar, 2026

Citi has added Apollo Hospitals to its Pan-Asia Focus List, maintaining a buy rating with a target price of ₹9,600, citing strong growth potential in its hospital and pharmacy segments.

Citi Reaffirms Buy Rating for Apollo Hospitals - 24 Mar, 2026

Apollo Hospitals Enterprise has successfully completed the acquisition of a 30.58% stake in Apollo Health and Lifestyle Limited, raising its ownership to 99.42%. This strategic move strengthens its position in the healthcare sector.

Apollo Hospitals Increases Stake in Subsidiary to 99.42% - 23 Mar, 2026

BofA Securities maintains a Buy rating on Apollo Hospitals Enterprise with a target price of ₹9,600, citing over 25% upside potential driven by margin expansion, digital growth, and a potential re-rating of HealthCo metrics.

BofA Securities Maintains Buy on Apollo Hospitals - 16 Mar, 2026

Price to Earnings Ratio or Price to Earnings Multiple is the ratio of the share price of a stock to its earnings per share (EPS). It provides an indication of whether a stock at its current market price is expensive or cheap.

The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company's market price, its earnings, and its future growth prospects.

Enterprise value (EV) is the total value of a company, defined in terms of its financing. It includes both the current share price (market capitalization) and the cost to pay off debt (net debt, or debt minus cash).

Alpha measures the amount that the investment has returned in comparison to the market index or other broad benchmark that it is compared against.

Beta measures a stock's volatility, the degree to which its price fluctuates in relation to the overall stock market. In other words, it gives a sense of the stock's risk compared to that of the greater market.

Dividend yield measures the quantum of earnings by way of total dividends that investors make by investing in that company.

The debt-to-total-assets ratio shows how much of a business is owned by creditors (people it has borrowed money from) compared with how much of the company's assets are owned by shareholders.

Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations.

This widget shows the information about the stock's peers in consideration along with the different data for those peers so that the user can compare the stock with the other similar stock and invest accordingly.

Promoter holding is the amount of share of the company that is owned by the promoters. The promoters are the company's founders, who hold a majority stake in the company's capital.

A foreign institutional investor (FII) is an investor or investment fund investing in a country outside of the one in which it is registered or headquartered.

A mutual fund is a pool of money managed by a professional Fund Manager. It is a trust that collects money from a number of investors who share a common investment objective and invests the same in equities, bonds, money market instruments, and other securities.

Retail investors execute their trades through traditional or online brokerage firms or other types of investment accounts. Retail investors purchase securities for their own personal accounts and often trade in dramatically smaller amounts as compared to institutional investors.

This widget shows the bifurcation of stocks based on the percentage of stake with the different types of shareholders.

This widget will help value the stock based on the Price to Earning ratio of the stock and compare the valuation with the industry value and other similar stocks. It even shows the timeline of the valuation of the stock and its highest and lowest valuation over time.
A Time Series data is provided which compares the historical stock PE with Industry PE over the period of 5 years.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

Netprofit is up for the last 5 quarters, 372.3 Cr → 502.3 Cr (in ₹), with an average increase of 7.2% per quarter

This section gives you an insight into how the profit for the company has been for the last few quarters.

Profit Spike

Revenue is up for the last 5 quarters, 5.59K Cr → 6.54K Cr (in ₹), with an average increase of 3.8% per quarter

This section gives you an insight into how the revenue of the company has moved for the last few quarters.

Revenue Rich

In the last 1 month, APOLLOHOSP stock has moved up by 0.4%

This section gives you an insight into the price movement of the stock for the last few quarters.

Price Rise

Promoters holdings remained unchanged at 28.02% of holdings in Mar 2026 quarter

This section gives you an insight into how the Promoter Holding has changed for the stock over the last few quarters.

Promoter Holding Unchanged

In the last 1 year, Fortis Healthcare Ltd has given 27.1% return, outperforming this stock by 18.2%

This section gives you an insight into how the peers have performed as compared to this company in the last 1 year.

Against Peers

In the last 3 years, Fortis Healthcare Ltd has given 221.0% return, outperforming this stock by 149.6%

This section gives you an insight into how the peers have performed as compared to this company in the last 3 years.

Retail Investor have decreased holdings from 6.71% to 6.37% in Mar 2026 quarter

This section gives you an insight into how the Retail Investors Holding has changed for the stock over last few quarters.

Retail Holding Down

Foreign Institutions have decreased holdings from 43.54% to 42.62% in Mar 2026 quarter

This section gives you an insight into how the FII Holding has changed for the stock over last few quarters.

FII Holding Down

Mutual Funds have decreased holdings from 16.75% to 16.65% in Mar 2026 quarter

This section gives you an insight into how the Mutual Funds Holding has changed for the stock over last few quarters.

MF Holding Down

Nifty Services Sector

Nifty Infra

Nifty India Consumption

S&P BSE 100 LargeCap TMC

NIFTY 50

BSE 100

Nifty100 Low Volatility 30

NIFTY 100

Nifty Healthcare

BSE 500

Nifty 500

Nifty LargeMidcap 250

S&P BSE Dividend Stability

Nifty 200

S&P BSE 250 LargeMidCap

S&P BSE Low Volatility

BSE 200

Nifty100 Eq Weig

S&P BSE 100 ESG

S&P BSE SENSEX 50

BSE Healthcare

Axis Large Cap Fund Direct Plan Growth

Mirae Asset Large Cap Fund Direct Plan Growth

HDFC Flexi Cap Fund -Direct Plan - Growth Option

Axis Focused Fund Direct Plan Growth Option

Franklin India Flexi Cap Fund Direct Growth

Apollo Hospitals Enterprise Ltd’s net profit jumped 34.92% since last year same period to ₹502.30Cr in the Q3 2025-2026. On a quarterly growth basis, Apollo Hospitals Enterprise Ltd has generated 5.26% jump in its net profits since last 3-months.

Apollo Hospitals Enterprise Ltd Earnings Results

In the quarter ending December 2025, Apollo Hospitals Enterprise Ltd has declared dividend of ₹10.00 per share on 10 Feb 2026 - translating a dividend yield of 0.39%.

Name	Value	Action
MACD level (12,26)	-4.31	Bearish
CCI (20)	-501.38	Bullish
RSI (14)	22.52	Bullish
Momentum (10)	-20.5	Bearish
ADI (14)	36.16	Bearish
Ultimate Oscillator (7,14,28)	56.89	Neutral

Name	Value	Action
SMA (20)	7640.18	Bearish
EMA (20)	7639.79	Bearish
VWMA (20)	7638.71	Bearish
SMA (50)	7645.68	Bearish
EMA (50)	7645.28	Bearish
SMA (200)	7653.28	Bearish
EMA (200)	7647.49	Bearish
KAMA (200)	7648.04	Bearish
DEMA (200)	7660.59	Bearish

Apollo Hospitals Enterprise Ltd (APOLLOHOSP)

Summary

Overall

Oscillators

Moving Averages